We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

All-in-One Device Increases Bedside Spirometry Testing

By HospiMedica International staff writers
Posted on 19 Jun 2017
A new spirometry solution helps primary care physicians conduct lung function testing at the point of care (POC).

The EasyOne Air is a portable, connected spirometry device that requires no calibration, warm-up time, or maintenance. An intuitive, full-color touch screen display ensures accurate and immediate results through real-time curves and parameters. The device connects via USB to a computer for direct printing and downloading, with an added option of portability through a secure Bluetooth connection, providing seamless integration to the patients’ electronic medical record (EMR) via EasyOne Connect, a platform for all EasyOne point-of-care solutions.

Image: The EasyOne Air portable, connected spirometry device (Photo courtesy of ndd Medical Technologies).
Image: The EasyOne Air portable, connected spirometry device (Photo courtesy of ndd Medical Technologies).

EasyOne Air is powered by propriety ultrasound flow technology that anticipates interfering variables, allowing it to function independently of gas composition, pressure, temperature, and humidity, thus ensuring a consistent, standardized test that is based on American Thoracic Society/European Respiratory Society (ATS/ERS) guidelines. Test types include FVC, FVL, SVC, MVV, and Pre/Post Testing. EasyOne Air is a product of ndd Medical Technologies (Zurich, Switzerland), and has been approved by the U.S. Food and Drug Administration (FDA).

“EasyOne Air is a flexible and reliable tool for healthcare professionals to accurately diagnose lung health. This new model includes ndd’s TrueFlow technology for the most accurate way to diagnose the growing number of patients suffering from COPD and other chronic lung diseases,” said Georg Harnoncourt, CEO of ndd Medical Technologies. “The earlier a physician can diagnose a patient, the faster they can offer treatment. The sooner a patient begins treatment, the better their quality of life.”

Spirometry is the most common pulmonary function test (PFT); it measures lung function, specifically the volume and/or flow of air inhaled and exhaled, which is helpful in assessing breathing patterns that identify conditions such as asthma, pulmonary fibrosis, cystic fibrosis, and chronic obstructive pulmonary disease (COPD). Spirometry generates pneumotachograph charts that plot the volume and flow of air coming in and out of the lungs from one inhalation and one exhalation.

Related Links:
ndd Medical Technologies


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Anesthesia Workstation
X40

Latest Critical Care News

Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment

Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs

On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants